• Home
  • Pharmaceuticals and Healthcare
Preimplantation Genetic Diagnostics (PGD) Market - Global Outlook and Forecast 2021-2027

Preimplantation Genetic Diagnostics (PGD) Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ687515 | No. of Pages: 110 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2021 
This report contains market size and forecasts of Preimplantation Genetic Diagnostics (PGD) in Global, including the following market information:
Global Preimplantation Genetic Diagnostics (PGD) Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Preimplantation Genetic Diagnostics (PGD) market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Preimplantation Genetic Diagnostics (PGD) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Preimplantation Genetic Diagnostics (PGD) Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Preimplantation Genetic Diagnostics (PGD) Market Segment Percentages, By Type, 2020 (%)
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis

China Preimplantation Genetic Diagnostics (PGD) Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Preimplantation Genetic Diagnostics (PGD) Market Segment Percentages, By Application, 2020 (%)
Fertility Clinics
Academic Medical Centers
Others

Global Preimplantation Genetic Diagnostics (PGD) Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Preimplantation Genetic Diagnostics (PGD) Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Preimplantation Genetic Diagnostics (PGD) Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Preimplantation Genetic Diagnostics (PGD) Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Illumina, Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Perkinelmer, Inc.
Cooper Surgical
ABBott Laboratories
Natera, Inc.
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Beijing Genomics Institute (BGI)
Genea Limited
Hamilton Thorne
FUJIFILM Irvine Scientific
Nidacon International
Vitrolife AB
Merck
INVO Bioscience
IVFtech
Gonagen Medikal
Cook Medical
CellCura
1 Introduction to Research & Analysis Reports
    1.1 Preimplantation Genetic Diagnostics (PGD) Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Preimplantation Genetic Diagnostics (PGD) Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Preimplantation Genetic Diagnostics (PGD) Overall Market Size
    2.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size: 2021 VS 2027
    2.2 Global Preimplantation Genetic Diagnostics (PGD) Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Preimplantation Genetic Diagnostics (PGD) Players in Global Market
    3.2 Top Global Preimplantation Genetic Diagnostics (PGD) Companies Ranked by Revenue
    3.3 Global Preimplantation Genetic Diagnostics (PGD) Revenue by Companies
    3.4 Top 3 and Top 5 Preimplantation Genetic Diagnostics (PGD) Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Preimplantation Genetic Diagnostics (PGD) Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Preimplantation Genetic Diagnostics (PGD) Players in Global Market
        3.6.1 List of Global Tier 1 Preimplantation Genetic Diagnostics (PGD) Companies
        3.6.2 List of Global Tier 2 and Tier 3 Preimplantation Genetic Diagnostics (PGD) Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Preimplantation Genetic Diagnostics (PGD) Market Size Markets, 2021 & 2027
        4.1.2 Preimplantation Genetic Screening
        4.1.3 Preimplantation Genetic Diagnosis
    4.2 By Type - Global Preimplantation Genetic Diagnostics (PGD) Revenue & Forecasts
        4.2.1 By Type - Global Preimplantation Genetic Diagnostics (PGD) Revenue, 2016-2021
        4.2.2 By Type - Global Preimplantation Genetic Diagnostics (PGD) Revenue, 2022-2027
        4.2.3 By Type - Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Preimplantation Genetic Diagnostics (PGD) Market Size, 2021 & 2027
        5.1.2 Fertility Clinics
        5.1.3 Academic Medical Centers
        5.1.4 Others
    5.2 By Application - Global Preimplantation Genetic Diagnostics (PGD) Revenue & Forecasts
        5.2.1 By Application - Global Preimplantation Genetic Diagnostics (PGD) Revenue, 2016-2021
        5.2.2 By Application - Global Preimplantation Genetic Diagnostics (PGD) Revenue, 2022-2027
        5.2.3 By Application - Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Preimplantation Genetic Diagnostics (PGD) Market Size, 2021 & 2027
    6.2 By Region - Global Preimplantation Genetic Diagnostics (PGD) Revenue & Forecasts
        6.2.1 By Region - Global Preimplantation Genetic Diagnostics (PGD) Revenue, 2016-2021
        6.2.2 By Region - Global Preimplantation Genetic Diagnostics (PGD) Revenue, 2022-2027
        6.2.3 By Region - Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Preimplantation Genetic Diagnostics (PGD) Revenue, 2016-2027
        6.3.2 US Preimplantation Genetic Diagnostics (PGD) Market Size, 2016-2027
        6.3.3 Canada Preimplantation Genetic Diagnostics (PGD) Market Size, 2016-2027
        6.3.4 Mexico Preimplantation Genetic Diagnostics (PGD) Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Preimplantation Genetic Diagnostics (PGD) Revenue, 2016-2027
        6.4.2 Germany Preimplantation Genetic Diagnostics (PGD) Market Size, 2016-2027
        6.4.3 France Preimplantation Genetic Diagnostics (PGD) Market Size, 2016-2027
        6.4.4 U.K. Preimplantation Genetic Diagnostics (PGD) Market Size, 2016-2027
        6.4.5 Italy Preimplantation Genetic Diagnostics (PGD) Market Size, 2016-2027
        6.4.6 Russia Preimplantation Genetic Diagnostics (PGD) Market Size, 2016-2027
        6.4.7 Nordic Countries Preimplantation Genetic Diagnostics (PGD) Market Size, 2016-2027
        6.4.8 Benelux Preimplantation Genetic Diagnostics (PGD) Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Preimplantation Genetic Diagnostics (PGD) Revenue, 2016-2027
        6.5.2 China Preimplantation Genetic Diagnostics (PGD) Market Size, 2016-2027
        6.5.3 Japan Preimplantation Genetic Diagnostics (PGD) Market Size, 2016-2027
        6.5.4 South Korea Preimplantation Genetic Diagnostics (PGD) Market Size, 2016-2027
        6.5.5 Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size, 2016-2027
        6.5.6 India Preimplantation Genetic Diagnostics (PGD) Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Preimplantation Genetic Diagnostics (PGD) Revenue, 2016-2027
        6.6.2 Brazil Preimplantation Genetic Diagnostics (PGD) Market Size, 2016-2027
        6.6.3 Argentina Preimplantation Genetic Diagnostics (PGD) Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Revenue, 2016-2027
        6.7.2 Turkey Preimplantation Genetic Diagnostics (PGD) Market Size, 2016-2027
        6.7.3 Israel Preimplantation Genetic Diagnostics (PGD) Market Size, 2016-2027
        6.7.4 Saudi Arabia Preimplantation Genetic Diagnostics (PGD) Market Size, 2016-2027
        6.7.5 UAE Preimplantation Genetic Diagnostics (PGD) Market Size, 2016-2027
7 Players Profiles
    7.1 Illumina, Inc.
        7.1.1 Illumina, Inc. Corporate Summary
        7.1.2 Illumina, Inc. Business Overview
        7.1.3 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.1.4 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.1.5 Illumina, Inc. Key News
    7.2 Thermo Fisher Scientific Inc.
        7.2.1 Thermo Fisher Scientific Inc. Corporate Summary
        7.2.2 Thermo Fisher Scientific Inc. Business Overview
        7.2.3 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.2.4 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.2.5 Thermo Fisher Scientific Inc. Key News
    7.3 Agilent Technologies, Inc.
        7.3.1 Agilent Technologies, Inc. Corporate Summary
        7.3.2 Agilent Technologies, Inc. Business Overview
        7.3.3 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.3.4 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.3.5 Agilent Technologies, Inc. Key News
    7.4 Perkinelmer, Inc.
        7.4.1 Perkinelmer, Inc. Corporate Summary
        7.4.2 Perkinelmer, Inc. Business Overview
        7.4.3 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.4.4 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.4.5 Perkinelmer, Inc. Key News
    7.5 Cooper Surgical
        7.5.1 Cooper Surgical Corporate Summary
        7.5.2 Cooper Surgical Business Overview
        7.5.3 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.5.4 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.5.5 Cooper Surgical Key News
    7.6 ABBott Laboratories
        7.6.1 ABBott Laboratories Corporate Summary
        7.6.2 ABBott Laboratories Business Overview
        7.6.3 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.6.4 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.6.5 ABBott Laboratories Key News
    7.7 Natera, Inc.
        7.7.1 Natera, Inc. Corporate Summary
        7.7.2 Natera, Inc. Business Overview
        7.7.3 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.4.4 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.7.5 Natera, Inc. Key News
    7.8 Rubicon Genomics
        7.8.1 Rubicon Genomics Corporate Summary
        7.8.2 Rubicon Genomics Business Overview
        7.8.3 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.8.4 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.8.5 Rubicon Genomics Key News
    7.9 Oxford Gene Technology
        7.9.1 Oxford Gene Technology Corporate Summary
        7.9.2 Oxford Gene Technology Business Overview
        7.9.3 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.9.4 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.9.5 Oxford Gene Technology Key News
    7.10 Yikon Genomics
        7.10.1 Yikon Genomics Corporate Summary
        7.10.2 Yikon Genomics Business Overview
        7.10.3 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.10.4 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.10.5 Yikon Genomics Key News
    7.11 Scigene
        7.11.1 Scigene Corporate Summary
        7.11.2 Scigene Business Overview
        7.11.3 Scigene Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.11.4 Scigene Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.11.5 Scigene Key News
    7.12 Beijing Genomics Institute (BGI)
        7.12.1 Beijing Genomics Institute (BGI) Corporate Summary
        7.12.2 Beijing Genomics Institute (BGI) Business Overview
        7.12.3 Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.12.4 Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.12.5 Beijing Genomics Institute (BGI) Key News
    7.13 Genea Limited
        7.13.1 Genea Limited Corporate Summary
        7.13.2 Genea Limited Business Overview
        7.13.3 Genea Limited Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.13.4 Genea Limited Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.13.5 Genea Limited Key News
    7.14 Hamilton Thorne
        7.14.1 Hamilton Thorne Corporate Summary
        7.14.2 Hamilton Thorne Business Overview
        7.14.3 Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.14.4 Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.14.5 Hamilton Thorne Key News
    7.15 FUJIFILM Irvine Scientific
        7.15.1 FUJIFILM Irvine Scientific Corporate Summary
        7.15.2 FUJIFILM Irvine Scientific Business Overview
        7.15.3 FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.15.4 FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.15.5 FUJIFILM Irvine Scientific Key News
    7.16 Nidacon International
        7.16.1 Nidacon International Corporate Summary
        7.16.2 Nidacon International Business Overview
        7.16.3 Nidacon International Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.16.4 Nidacon International Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.16.5 Nidacon International Key News
    7.17 Vitrolife AB
        7.17.1 Vitrolife AB Corporate Summary
        7.17.2 Vitrolife AB Business Overview
        7.17.3 Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.17.4 Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.17.5 Vitrolife AB Key News
    7.18 Merck
        7.18.1 Merck Corporate Summary
        7.18.2 Merck Business Overview
        7.18.3 Merck Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.18.4 Merck Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.18.5 Merck Key News
    7.19 INVO Bioscience
        7.19.1 INVO Bioscience Corporate Summary
        7.19.2 INVO Bioscience Business Overview
        7.19.3 INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.19.4 INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.19.5 INVO Bioscience Key News
    7.20 IVFtech
        7.20.1 IVFtech Corporate Summary
        7.20.2 IVFtech Business Overview
        7.20.3 IVFtech Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.20.4 IVFtech Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.20.5 IVFtech Key News
    7.21 Gonagen Medikal
        7.21.1 Gonagen Medikal Corporate Summary
        7.21.2 Gonagen Medikal Business Overview
        7.21.3 Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.21.4 Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.21.5 Gonagen Medikal Key News
    7.22 Cook Medical
        7.22.1 Cook Medical Corporate Summary
        7.22.2 Cook Medical Business Overview
        7.22.3 Cook Medical Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.22.4 Cook Medical Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.22.5 Cook Medical Key News
    7.23 CellCura
        7.23.1 CellCura Corporate Summary
        7.23.2 CellCura Business Overview
        7.23.3 CellCura Preimplantation Genetic Diagnostics (PGD) Major Product Offerings
        7.23.4 CellCura Preimplantation Genetic Diagnostics (PGD) Revenue in Global (2016-2021)
        7.23.5 CellCura Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer


List of Tables and Figures
Ask Sample Report to get more details…

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com